TYLER, Texas, Sept. 19, 2006 (PRIMEZONE) -- Biogenerics Limited (Pink Sheets:BIGN) announced that the Company has directed change in the utilization of its Investor Relations Department. Biogenerics Ltd has concluded that it is in the best interest of the shareholders to convert the department to "virtual access." The Company's policy has always been to disseminate information fairly to all shareholders as per Regulation FD (Fair Disclosure). Biogenerics website (www.bignltd.com) has been streamlined to provide updated business developments as well as access to the Company's press releases. The department will now respond to inquiries submitted by email and will be addressed on a regular basis by an Investor Relations Official. The streamlined virtual version will allow existing and potential investors access to the up-to-date business activity of Biogenerics Ltd.
The Board of Directors also announced the Company has increased the authorized share capital amount by 400 million shares. The decision was made to allow the Company to continue to aggressively pursue current and future acquisitions.
Website: http:/www.bignltd.com
About Biogenerics Limited
Biogenerics is a diversified investment venture capital firm focused on exploiting and distributing domestic oil and gas reserves. Biogenerics also has joint venture activities with Tyche Energy and Hydroslotter Corporation.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.